No Result
View All Result
Success American Investors
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Success American Investors
No Result
View All Result
Home Stock

Gadsby Wicks Triumphs with Compensation for Client Following Delayed Diagnosis and GP Negligence

by
August 1, 2023
in Stock
0
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Gadsby Wicks, a specialised medical negligence firm serving Essex and East Anglia, successfully secured compensation for a client who suffered due to delayed treatment of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR).

Tony Mitty, an experienced solicitor and Partner at Gadsby Wicks, handled the case for the claimant, where unnecessary delays in diagnosis and GP negligence resulted in a poor and avoidable outcome.

The Case:

The claimant, Mrs F (name anonymised to protect privacy), consulted her GP with symptoms of a dull ache in her shoulder joints, hips, and upper legs, along with limited movement. Unfortunately, no meaningful action was taken at this point.

A month later, Mrs F returned with worsening symptoms, struggling to get in and out of bed and facing difficulty climbing stairs. She also experienced constant aching from her forehead to the top of her head, severe jaw pain while eating, and soreness in her left temple upon touch. Yet again, no significant action was taken.

Another month-and-a-half later, Mrs F’s vision in her left eye became blurred, leading her to seek help at her local A&E and subsequent admission. Tragically, she lost all vision in her left eye a few days later.

Mrs F was later diagnosed with Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR). Treatment included blood transfusions and high-dose steroid medication, which resulted in side effects like Cushing’s Disease.

The Claim:

Mrs F pursued the claim based on the assertion that her GP should have diagnosed and treated her for PMR during her initial consultation. Early treatment with low-dose steroids could have prevented the side effects she now experiences.

Additionally, during her second visit, the GP should have recognised signs and symptoms of GCA and initiated investigations and treatment to prevent the loss of vision in her left eye.

The Outcome:

Following Gadsby Wicks’ investigation into the case, legal proceedings were issued. Initially, the Defendants denied both breach of duty and causation. However, the claim was eventually settled out of court following the exchange of expert evidence.

The outcome provided fair compensation for the pain, suffering, and difficulties Mrs F endured, and brought her much-needed answers and closure.

Tony Mitty, the medical solicitor on Mrs F’s case, expressed his thoughts, “It is always unfortunate when a patient’s poor outcome could have been entirely prevented with earlier intervention from a healthcare professional, especially when there were multiple opportunities such as this case.”

He added, “Although we cannot turn back the clock on our client’s mistreatment, I am glad that we could help her secure a successful result in her claim. I am confident that the compensation awarded will provide Mrs F with invaluable support as she moves on from this incident, hopefully preventing others from facing the same result.”

Gadsby Wicks has seen an increase in delayed treatment claims in the previous 12 months. The firm remains dedicated to achieving the best outcomes for clients who suffered due to avoidable delays in their care.

The post Gadsby Wicks Triumphs with Compensation for Client Following Delayed Diagnosis and GP Negligence first appeared on BusinessMole.

Previous Post

Therapy For You Unveils Limbic: An Innovative Mental Health Chatbot for Enhanced Access to Talking Therapies

Next Post

Statism and the Unmaking of Reality

Next Post
Statism and the Unmaking of Reality

Statism and the Unmaking of Reality

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

February 14, 2024

Last Day to Give in 2023!

December 31, 2023
Idaho Bucks Managed Care Trend

Idaho Bucks Managed Care Trend

December 5, 2023

The Producer Price Index

September 9, 2023

Unlocking Potential: Maximizing Gains for XRP Holders in 2025 with Fash Hash Cloud Mining for a $5000 Daily Profit

0

0

0

0

Unlocking Potential: Maximizing Gains for XRP Holders in 2025 with Fash Hash Cloud Mining for a $5000 Daily Profit

June 1, 2025

The Southern Cause: What Led to Secession

May 31, 2025

“Our Marx”: The Great Herbert Spencer

May 31, 2025
UK steel industry faces fresh crisis as US tariff jumps to 50%

UK steel industry faces fresh crisis as US tariff jumps to 50%

May 31, 2025

Recent News

Unlocking Potential: Maximizing Gains for XRP Holders in 2025 with Fash Hash Cloud Mining for a $5000 Daily Profit

June 1, 2025

The Southern Cause: What Led to Secession

May 31, 2025

“Our Marx”: The Great Herbert Spencer

May 31, 2025
UK steel industry faces fresh crisis as US tariff jumps to 50%

UK steel industry faces fresh crisis as US tariff jumps to 50%

May 31, 2025

Disclaimer: SuccessAmericanInvestors.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.